Raltegravir has one of the lowest rates of discontinuation for side effects of any antiretroviral. Most people take it without noticing anything.
What happens in the first weeks?
Headache, nausea, tiredness and abdominal discomfort occur in a minority and generally settle within two to four weeks. They are mild where they occur.
Why is it so well tolerated?
Partly because integrase has no human equivalent, so a drug blocking it interferes little with normal cellular processes. Partly because it needs no booster, which removes a whole category of effects.
What about sleep?
Insomnia and vivid dreams are reported with integrase inhibitors as a class and appear less frequently with raltegravir than with some others. Where they occur they are worth mentioning rather than absorbing.
What about mood?
Depression and anxiety have been reported at low rates. Any mood change appearing after starting is worth raising rather than attributing to circumstances, since the timing is informative.
What about muscle problems?
The one to know about. Raised muscle enzymes, muscle pain and weakness occur uncommonly, and rhabdomyolysis, where muscle tissue breaks down and can affect the kidneys, has been reported rarely.
What should prompt attention?
Unexplained severe muscle pain or weakness, particularly with dark urine, warrants prompt assessment rather than waiting. This is uncommon and it is worth knowing about because the symptoms are easy to attribute to exercise.
Does that rule out the gym?
No. Ordinary muscle soreness after exercise is not the concern. What matters is pain out of proportion to what you have done, or weakness, or urine that has turned dark.
What about skin reactions?
Rash occurs uncommonly and is usually mild. Severe reactions including Stevens-Johnson syndrome have been reported rarely. Any rash with fever, blistering, peeling skin, or involvement of the mouth or eyes is an emergency.
What about lipids?
Favourable. Cholesterol and triglycerides are generally better on raltegravir than on efavirenz or boosted protease inhibitors, and switching from those improves them.
What about weight?
Weight gain across the integrase class appears less pronounced with raltegravir in some analyses. That is a reason it is sometimes considered for people who have gained weight on another integrase inhibitor.
What about the liver?
Liver enzyme rises occur uncommonly and are monitored, more often in people with hepatitis B or C. Yellowing of the eyes or skin, dark urine or pain under the right ribs warrant prompt contact.
What about kidneys?
Nothing attributable to raltegravir. Kidney monitoring on a combination containing it relates to a tenofovir component rather than to this drug.
Do side effects mean it is working?
No, and their absence does not mean it is not. There is no relationship between how you feel and how well the virus is suppressed. Blood tests are the only reliable measure.
What monitoring is there?
Blood tests every three to six months covering viral load, kidney and liver function and lipids. Muscle enzymes are checked where there is a reason to.
When should you contact your clinic?
Severe muscle pain or weakness, any rash with systemic symptoms, anything lasting beyond a month, or anything making you consider stopping.
Should you look side effects up online?
The leaflet lists everything ever reported, which is alarming and unhelpful for judging likelihood. A clinic pharmacist will tell you which effects are common and which matter, in about two minutes.